Table 3.
Positive secondary effects* of treatment with CBD-rich Cannabis extracts and purified CBD described as secondary endpoints in the clinical studies.
| Treatment references | Patients | Mood | Alertness | Behav. | Sleep | Language | Motor |
|---|---|---|---|---|---|---|---|
| Total reports | 508 | 151/226 | 275/508 | 91/224 | 150/447 | 51/149 | 28/268 |
| Mean | 100% | 67% | 54% | 41% | 34% | 34% | 10% |
| CBD pure (9) | 9/14 | NR | 86% | 67% | NR | NR | NR |
| CBD pure (10) | 47 | 57% | 68% | 42% | NR | 67% | NR |
| CBD-rich extract (11) | 19 | 79% | 74% | 32% | 68% | NR | NR |
| CBD-rich extract (12) | 117 | 63% | 71% | NR | 53% | NR | NR |
| CBD-rich extract (28) | 75 | NR | 33% | 33% | 7% | 11% | 11% |
| CBD-rich extract (13) | 74 | NR | 34% | 34% | 11% | 15% | 15% |
| CBD-rich extract (14) | 43 | 83% | 89% | NR | 77% | NR | NR |
| CBD-rich extract (15) | 119 | NR | 39% | NR | 7% | NR | 8% |
*
Only those reported by at least 5% of the study population are listed. NR, not reported.